The primary objective of this study is to investigate the efficacy of EMDR therapy in reducing pain interference in the life*s of children with SCD. Secondary objectives are to study the efficacy of EMDR in reducing PTSD symptoms, anxiety,…
ID
Source
Brief title
Condition
- Haemoglobinopathies
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
Primary outcomes is pain interference in the child*s life, measured with PROMIS
Pain Interference questionnaire.
PROMIS Pain Interference (parent-report for children aged 6-7 and pediatric
self-report from 7 years on):
We will use the PROMIS Short Form - Pain Interference 8a for measuring Pain
interference. The PROMIS Pain Interference questionnaire assess the pain impact
on relevant aspects of one*s life. This includes the extent to which pain
affects social, cognitive, emotional, physical, and recreational activities. It
also incorporates items probing sleep and enjoyment in life. The questionnaire
assesses pain interference over the past seven days (recall period). A higher
PROMIS T-score represents more pain interference. This scale ranges from 0-100
points. In his dissertation, Luijten reports that the general Dutch pediatric
population reports a mean score of 39 points with a standard deviation of 10
points. Therefore, T-scores of 49 and above represent (sub)clinical level of
functioning. On previous study from our group (submitted), children with
severe SCD phenotype (n= 36) reported a mean score of 52.73 points (SD= 12.72),
while the ones with less severe SCD phenotype (n= 54) reported a mean score of
47.35 points (SD= 13.82).
Secondary outcome
• Severity of PTSD symptoms during/after intervention:
PTSD symptoms score reported via the Child and Adolescent Trauma Screen (CATS)
questionnaire (parent-report for children aged 6-7 and pediatric self-report
from 7 years on):
The Child and Adolescent Trauma Screen (CATS) questionnaire is a screening
instrument based on the fifth edition of the Diagnostic and Statistical Manual
of Mental Disorders (DSM-5) criteria for PTSD. It is a measure of potentially
traumatic events and of PTSS. These questionnaires are composed of 15 items
measuring traumatic events, 20 items measuring DSM-5 PTSD symptoms, and 5 items
measuring psychosocial functioning, and is administered in approximately 15
minutes. The 4-point symptom response scales indicate the reported
frequency/severity of each symptom. For the children aged 6 years, using the
Caregiver-report, the possible score range is 0 - 48, and the recommended
cut-off point indicative of (sub)clinically relevant level of symptoms is of 12
points or more. For children aged 7 years and older, using the Self-report
version, the possible score range is 0 - 60, and the cut-off point is of 15
points or more.
• Anxiety of participants (parent-report for children aged 6-7 and pediatric
self-report from 7 years on):
General anxiety score reported via PROMIS Anxiety questionnaire:
PROMIS Anxiety questionnaires assess the fear (fearfulness, panic), anxious,
misery (worry, dread), hyperarousal (tension, nervousness, restlessness), and
somatic symptoms related to arousal (racing heart, dizziness). They assess
anxiety over the past seven days (recall period). The PROMIS T-scores are
calculated per version. A higher PROMIS T-score represents more anxiety.
• Depressive symptoms of participants (parent-report for children aged 6-7
and pediatric self-report from 7 years on):
PROMIS Depressive Symptoms questionnaires assess negative mood (sadness,
guilt), views of self (self-criticism, worthlessness), and social cognition
(loneliness, interpersonal alienation), as well as decreased positive affect
and engagement (loss of interest, meaning, and purpose). Somatic symptoms
(changes in appetite, sleeping patterns) are not included, which eliminates
consideration of these item*s confounding effects when assessing children with
comorbid physical conditions. The questionnaires are universal rather than
disease-specific, making scores easily comparable to the general population.
They assess depressive symptoms over the past seven days (recall period). The
PROMIS T-scores are calculated per version. A higher PROMIS T-score represents
more depressive symptoms.
• Physical complaints (parent-report for children aged 6-7 and pediatric
self-report from 7 years on):
These questionnaires assess activities of physical mobility such as getting out
of bed or a chair to activities such as running. They assess mobility over the
past seven days (recall period). The PROMIS T-scores are calculated per
version. A higher PROMIS T-score represents more mobility.
• Pain severity and intensity, pain medication and school absence:
At 3 measurement moments (T0, T1, T1.1. and T2) participants, should complete
a diary and report for each day of the week if they had pain and rate the
severity of the pain on a numeric rating scale (NRS), and any pain medication
used and if they went to school.
Pain severity will also be investigated before and after each EMDR session
using the same measurement tool, and will be registered by the therapist as
part of the session report.
• Feasibility of EMDR intervention:
At T1i/T1.1c (2 weeks after the last EMDR session), the EMDR treatment
feasibility will be evaluated via a semi-structured interview performed by the
researcher with the participants.
Background summary
Children with sickle cell disease (SCD) suffer from vaso-occlusive episodes
(VOE), extremely painful acute episodes that may occur frequently (on average
3x/year), unexpectedly, and usually last several days. The severity of pain of
these VOE may require hospitalization for the administration of morphine.
Traumatic experiences during hospitalization may lead to the development of
(subclinical) posttraumatic stress disorder (PTSD). A first-choice treatment
for PTSD is Eye Movement Desensitization and Reprocessing (EMDR) therapy.
Studies demonstrated the efficacy of EMDR in decreasing PTSD symptoms in
children and adolescents, EMDR therapy is also reported to be effective in
treating acute and chronic pain symptoms in adults. EMDR, however, has not been
studied for children and for SCD populations with the aim of reduction in pain
interference.
Study objective
The primary objective of this study is to investigate the efficacy of EMDR
therapy in reducing pain interference in the life*s of children with SCD.
Secondary objectives are to study the efficacy of EMDR in reducing PTSD
symptoms, anxiety, depressive symptoms, physical complaints (low mobility),
frequency and severity of pain, use of pain medication, and number of days
absent from school. Themes of pain and trauma related memories and feasibility
of EMDR therapy for this population will also be explored.
Study design
In this single-center randomized controlled trial (RCT) patients (age 6-18
years) with SCD and clinical relevant scores on PROMIS pain interference will
be randomized into an intervention group and wait-list control group.
Measurements will be done for the complete study population at inclusion (T0).
In the intervention group measurements will be done 2 weeks (T1i) and 3 months
(T2i) after the end of EMDR sessions. Eight weeks after inclusion (T1c) will be
performed for participants in the wait-list control group just before they
receive EMDR treatment, and they are asked to complete measurements, 2 weeks
(T1.1c) and 3 months after the end of EMDR sessions (T2c).
Intervention
After the intake session (week 1), including case conceptualization and
treatment plan, a maximum of 6 weekly EMDR sessions with a duration of 1 hour
per session will be offered. The wait-list control group will wait 9 weeks
before starting EMDR therapy.
Study burden and risks
This research may benefit the subjects (therapeutic), with the potential to
reduce pain interference and PTSD symptoms. Participants will spend a maximum
total of 7.5 hours for EMDR therapy (including intake). At home, per
measurement moment, the maximum estimated time to answer to all questionnaires
online is approximate 15 minutes. Participation in the study is associated with
negligible risks for children and their parents. EMDR is proven to be a safe,
well tolerated treatment, even for very vulnerable patients. EMDR will be
offered by qualified therapists and is part of standard care in the children*s
hospital. As with any form of psychotherapy, there may be a mild temporary
increase in distress, caused by processing of the information discussed with
the therapist. However EMDR is proven to be very effective in decreasing stress
levels immediately and after the session. The therapist will be available for
the patients in case they need support in between EMDR sessions. Moreover,
participants/parents will be told at the last treatment day that they can call
at any time if they need more psychological support before the end of the
study. In addition, 3 months after completion of the EMDR participants will be
called by the research team to ask if they need more psychosocial support.
Participating in this study may be beneficial in different ways. Firstly, in
case the treatment is proven to be effective in reducing pain interference, it
will contribute to clinical care as a non-invasive and non-pharmacological
treatment of SCD. Secondly, when efficacy of EMDR for SCD pain interference is
demonstrated, this intervention may be further studied for children with SCD
suffering from pain world-wide and children with other types of pain, may also
benefit from the use of EMDR therapy.
Meibergdreef 9
Amsterdam 1105 AZ
NL
Meibergdreef 9
Amsterdam 1105 AZ
NL
Listed location countries
Age
Inclusion criteria
• Medical diagnosis of SCD;
• Age between 6 and 18 years old;
• Elevated pain interference scores:
Reporting above the clinical cut-off t-score of 49 on PROMIS Pain
Interference (parent-proxy version for children from 6-7 years and self-report
version for children from 8 years).
• Having sufficient knowledge of the Dutch or English languages to complete the
assessments;
Exclusion criteria
• Undergone succesful stem cell transplantation;
• Pregnant adolescents;
• Current unsafety that is likely to interfere with psychological therapy for
example ongoing domestic violence;
• Major interfering acute medical or psychiatric condition, such as psychosis,
substance dependence, current severe self-harm or high risk for suicide
requiring immediate treatment;
• Receiving psychological (trauma) treatment by another therapist at the same
time;
• IQ estimated to be < 80 based on information contained in the medical history
or information from educational services/school.
Design
Recruitment
Medical products/devices used
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL86274.018.24 |